The MDM2 polymorphism SNP309 is associated with clinical characteristics and outcome in diffuse large B-cell lymphoma
Introduction The murine double minute 2 (MDM2) gene encodes a regulatory protein of the p53 pathway. A single nucleotide polymorphism (T to G change) at position 309 (SNP309) in the promotor region of MDM2 affects the transcription activity of MDM2 and has been found to be a negative prognostic mar...
Main Authors: | Hedstrom, Gustav, Thunberg, Ulf, Amini, Rose-Marie, Zainuddin, Norafiza, Enblad, Gunilla, Berglund, Mattias |
---|---|
Format: | Article |
Language: | English English |
Published: |
John Wiley & Sons Ltd
2014
|
Subjects: | |
Online Access: | http://irep.iium.edu.my/43697/ http://irep.iium.edu.my/43697/ http://irep.iium.edu.my/43697/ http://irep.iium.edu.my/43697/4/Hedstrm_et_al-2014-European_Journal_of_Haematology_%281%29.pdf http://irep.iium.edu.my/43697/7/43697-The%20MDM2%20polymorphism%20SNP309_SCOPUS.pdf |
Similar Items
-
Lack of association between the MDM2 promoter polymorphism SNP309 and clinical outcome in chronic lymphocytic leukimia
by: Kaderi, Mohd Arifin, et al.
Published: (2010) -
Quantitative evaluation of p16INK4a promoter methylation using pyrosequencing in de novo diffuse large B-cell lymphoma
by: Zainuddin, Norafiza, et al.
Published: (2011) -
TP53 mutations predict for poor survival in de novo diffuse
large B-cell lymphoma of germinal center subtype
by: Zainuddin, Norafiza, et al.
Published: (2008) -
Methylation status of MGMT and SPOCK2 in diffuse large B-cell lymphoma
by: Zainuddin, Norafiza, et al.
Published: (2016) -
Epigenetic methylation status of P16, MGMT and SPOCK2 in diffuse Large B cell lymphoma
by: Mohd. Ridah, Lailatul Jalilah, et al.
Published: (2016)